Switch to
More onapp

How to use scorecard? Learn more

Indrayani Biotech Ltd

INDRANIB
Information TechnologySoftware Services
SmallcapWith a market cap of ₹296 cr, stock is ranked 1,977
High RiskStock is 5.32x as volatile as Nifty
65.650.96 (+1.48%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Avg

Financials growth has been moderate for a few years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Information TechnologySoftware Services
SmallcapWith a market cap of ₹296 cr, stock is ranked 1,977
High RiskStock is 5.32x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
40.75
PB RatioPB Ratio
6.13
Dividend YieldDiv. Yield
Sector PESector PE
33.91
Sector PBSector PB
9.03
Sector Div YldSctr Div Yld
2.06%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Indrayani Biotech is engaged in providing travel technology and solutions.

Financial TrendFinancial statements 

202020212022202350.1021.3661.79167.420.82-11.214.4411.95
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 11.26%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Board Meeting 
Announced OnFeb 4, 2024

INDRAYANI BIOTECH LTD. - 526445 - Board Meeting Intimation for Board Meeting Intimation For Considering And Approving The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter & Nine Months Ended December 31, 2023, And Any Other Business With The Permission Of The Chair. | Download

INDRAYANI BIOTECH LTD. - 526445 - Board Meeting Intimation for Board Meeting Intimation For Considering And Approving The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter & Nine Months Ended December 31, 2023, And Any Other Business With The Permission Of The Chair. | Download

Company Update 
Announced OnJan 21, 2024

INDRAYANI BIOTECH LTD. - 526445 - Announcement Under Regulation 30 - Clarification Regarding Significant Movement In Price | Download

INDRAYANI BIOTECH LTD. - 526445 - Announcement Under Regulation 30 - Clarification Regarding Significant Movement In Price | Download

Board Meeting 
Announced OnJan 6, 2024

INDRAYANI BIOTECH LTD. - 526445 - Board Meeting Intimation for Proposal For Increasing The Authorised Share Capital And Approval For Conversion Of Unsecured Loans Into Equity Under Section 62(3) Of The Companies Act, 2013 Subject To Shareholders'' Approval | Download

INDRAYANI BIOTECH LTD. - 526445 - Board Meeting Intimation for Proposal For Increasing The Authorised Share Capital And Approval For Conversion Of Unsecured Loans Into Equity Under Section 62(3) Of The Companies Act, 2013 Subject To Shareholders'' Approval | Download

See all events